Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on April 14, 2026

Apr. 14, 2026

Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity

Indeterminate GlobeNewswire

Apr. 14, 2026

Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts

Indeterminate GlobeNewswire

Apr. 14, 2026

Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline

Indeterminate GlobeNewswire

Apr. 14, 2026

Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay

Indeterminate GlobeNewswire

Apr. 14, 2026

Calidi Biotherapeutics Announces Speaker Presentation at IOVC Conference in Reykjavík, Iceland on April 28th Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy

Indeterminate GlobeNewswire

Apr. 14, 2026

Aclarion Receives Pinnacle Award for AI Innovation

Indeterminate GlobeNewswire

Apr. 14, 2026

R1 Announces Revenue Performance Solutions Powered by Phare OS to Help Providers Navigate Growing Complexity and Margin Pressure

Indeterminate GlobeNewswire

Apr. 14, 2026

Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One

Indeterminate GlobeNewswire

Apr. 14, 2026

Clairity Announces Update to NCCN Guidelines to Include AI Mammogram-Based Risk Tool to Identify Future Breast Cancer Risk in Women Missed by Traditional Methods

Indeterminate GlobeNewswire

Apr. 14, 2026

AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting

Indeterminate GlobeNewswire

Apr. 14, 2026

Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Indeterminate GlobeNewswire

Apr. 14, 2026

Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026

Indeterminate GlobeNewswire

Apr. 14, 2026

Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference

Indeterminate GlobeNewswire

Apr. 14, 2026

Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor

Indeterminate GlobeNewswire

Apr. 14, 2026

Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease

Indeterminate GlobeNewswire

Apr. 14, 2026

Medicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

Indeterminate GlobeNewswire

Apr. 14, 2026

Avacta CEO Christina Coughlin Named as One of In Vivo's 2026 Rising Leaders

Indeterminate GlobeNewswire

Apr. 14, 2026

Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board

Indeterminate GlobeNewswire

Apr. 14, 2026

Trained Therapeutix Discovery’s Chief Scientific Officer, Dr. Mulder, Honored with Fellowship at the American Institute for Medical and Biological Engineering (AIMBE)

Indeterminate GlobeNewswire

Apr. 14, 2026

Shopify to Announce First-Quarter 2026 Financial Results May 5, 2026

Indeterminate GlobeNewswire